Danicamtiv | Interleukin Related interleukin-related.com

Product Name :
Danicamtiv

Search keywords :
Danicamtiv

drugId :
null

Target Vo:
Cardiac myosin

Target Vo Short Name :
Cardiac myosin

Moa_Name:
Cardiac myosin stimulants

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Myokardia Inc

Active Company_Name :
Bristol-Myers Squibb Company

Active Indication_Name:
Cardiomyopathy, Dilated

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Histone H4 Rabbit mAb site
Tarextumab medchemexpress
Cyclin E1 Antibody (YA483): Cyclin E1 Antibody (YA483) is a non-conjugated and Rabbit origined monoclonal antibody about 47 kDa, targeting to Cyclin E1. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse.

Author: Interleukin Related

Related Posts